ArticleMolecular therapy oncolytics2022

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models.

Dongjoon Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.